The SGC releases its first crop of TEPs to accelerate drug discovery
3rd Epigenetic Methyltransferases;
Structure, Mechanism and Inhibition Symposium
Chestnut Residence & Conference Centre
August 24th 2017, Toronto, Canada
The SGC is a public-private partnership that supports the discovery of new medicines through open access research.
Created, discovered and shared by the SGC without restriction on use: innovation for everyone.
A Global network of multi-talented and multi-cultural team of cross-disciplinary scientists: all committed to accelerate drug discovery.